Stryker Corporation (SYK)
Makes surgical equipment and joint replacement implants for hospitals and doctors.
$346.66+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-7.7%
The outlook
Stryker has strong analyst backing with a consensus Buy rating across 25 analysts. The stock sits comfortably above both its 50- and 200-day moving averages, roughly midway through its 52-week range, with the average analyst price target about 11% above current levels. The overall picture leans bullish, though the trailing P/E of 40.1 reflects a premium valuation.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 25 analysts
Price trendAbove its 50- & 200-day averages
52-week range53% of the way from its 52-week low to high
Price targetAvg target +11% vs current price
Analyst price target
~12-month · 25 analysts$386.52average target+11.5% vs now
Now $346.66
Low $315.00High $465.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$132.90B
52-wk high
$403.92
52-wk low
$281.00
50-day avg
$314.61
200-day avg
$343.69
Trailing P/E
40.1